WPI 3355 (Nateglinide 120 mg)
Pill with imprint WPI 3355 is Pink, Capsule-shape and has been identified as Nateglinide 120 mg. It is supplied by Watson Laboratories Inc..
Nateglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Nateglinide 120 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3355
Nateglinide
- Imprint:
- WPI 3355
- Strength:
- 120 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Meglitinides
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Laboratories Inc.
- Inactive Ingredients:
- silicon dioxide colloidal
fumaric acid
hypromellose 2910 (3 mPa.s)
lactose monohydrate
magnesium stearate
polysorbate 80
sodium starch glycolate type A potato
corn starch
titanium dioxide
hypromellose 2910 (6 mPa.s)
FD&C Red No. 40
aluminum oxide
ferric oxide red
ferric oxide black
Note: Inactive ingredients may vary.
More about nateglinide
- Nateglinide Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 2 Reviews
- Drug class: meglitinides
Consumer resources
Other brands: Starlix
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
